Derived exclusively from peer-reviewed clinical trials and credible research institutions. 100% independent and non-profit.
Documented liver failure, kidney damage, cancer, or deaths. Several of these are still legally sold in the United States — including one that's just an FDA warning away from a recall.
Up to 40% of the weight lost on a GLP-1 drug can be muscle. Protein and resistance training do the heavy lifting — here's exactly where creatine, HMB, vitamin D and omega-3 fit, and what to skip.
For most young athletes, food, sleep and training beat anything in a tub — and the real risks are contamination and stimulants. What's safe, what's hype, and the straight answer on creatine for teens.
Your liver and kidneys already detoxify you. No supplement can improve on millions of years of evolution — but the industry banks on you not knowing that.
Berberine does lower blood sugar — but comparing it to GLP-1 receptor agonists misrepresents both the mechanism and the evidence. Here's what a 500mg dose actually does, and what it doesn't.
The TikTok-to-trial-data gap, in 10 entries. Sea moss, turkesterone, NMN, lion's mane and more — supplements with huge marketing budgets and shockingly thin clinical evidence.
The April 2026 CDC MMWR reviewed 1,955 kava calls to U.S. poison centers. Serious outcomes peaked at 39% in 2024. Kratom co-use is driving the worst cases.
$5 of creatine has more clinical evidence behind it than every $1,500-a-month NAD+ IV combined. Price ≠ evidence — here's the full split between the cheap proven workhorses and the premium-priced lab toys.
NMN and NR are sold as anti-aging miracles. The mouse data is compelling — but human trials tell a much more nuanced story. Here's what's real.
High-dose turmeric extracts have triggered over 30 cases of severe hepatotoxicity. We break down who's at risk, what dose is safe, and which forms to avoid.
Pediatric melatonin ER visits rose 530% from 2012–21. St. John's Wort + SSRIs. Kava + alcohol. Twelve mistakes with documented hospital outcomes — and the people who keep making them.
The $61B probiotic market sells you billions of CFUs that mostly die in stomach acid before they reach your gut. Here's which strains have the trials to back them up — and which are pure marketing.
The skin and joint claims have more marketing than evidence behind them. Here's what hydrolyzed collagen actually does — and a cheaper alternative that works just as well.
Published case series tie high-dose EGCG extracts to acute liver injury and transplant. Brewed green tea is safe — but the concentrated capsules are a very different story.
More high-quality trial evidence than almost any supplement on the market — yet wellness culture ignores it. LDL down 15 mg/dL. HbA1c down 0.4%. FDA-approved heart health claim since 1998. Here is why nobody is talking about it.
Two new meta-analyses (Prokopidis 2023, Xu 2024) confirm creatine improves memory and cognition in healthy adults — not just athletes. The effect is real, but smaller than the marketing claims.
St. John's Wort, berberine, magnesium, melatonin — the supplements that interact with the most prescription drug classes. The list that should be taped to every medicine cabinet.
The only magnesium form proven to cross the blood-brain barrier in animal studies. But do the human trials actually back up the cognitive claims? We dig into all four studies.
95% of U.S. adults fall short on fibre. 90% on choline. 90% on omega-3. The 10 nutrients where pills genuinely fill a population-wide gap — not the trendy ones.
Electrolyte mixes have gone mainstream. We compare sodium-to-sugar ratios, cost per serving, and whether you can make the same thing at home for a fraction of the price.
A personalized supplement stack ranked by the same evidence database behind 733 supplement scores — tailored to your age, goals, and health.
What brought you here today?
Pick one or more goals — we'll weight your plan around them.
How do you want your plan?
You can always switch later from your dashboard.
About you
Used to calibrate doses and filter unsuitable supplements.
Any conditions?
Tap all that apply — sorted by relevance to your goal.
Any medications?
We'll filter out supplements that interact. What's in your cabinet?
Add only what you take regularly. Skip if none.
Health status
Helps us filter supplements that stress the kidneys or liver.
Blood work (optional)
Upload a lab PDF for more precise recommendations and tighter doses. 100% client‑side · nothing leaves your browser.
Skip if you don't have recent labs — the engine still works, it just uses population averages instead of your numbers.
Optional — only used to notify you if your plan can be optimized as new research lands. We won't email you for anything else.
We built SupplementScore to fix the most broken part of wellness: the gap between what a label says and what the clinical evidence actually shows. Every score traces back to peer-reviewed research. No sponsorships, no affiliates, no ads.
Every supplement is classified by the strength and consistency of its human clinical data.
Four steps from the literature to a score you can trust.
Priority for systematic reviews, meta-analyses, and Cochrane reviews. Individual RCTs used when no meta-analysis exists. Industry-funded studies flagged and weighted lower.
Each study graded for blinding, allocation concealment, sample size, and statistical power. Effect sizes and confidence intervals recorded for every key outcome.
Rated across 6 dimensions: Efficacy, Safety, Research depth, Onset time, Cost-effectiveness, and Drug interactions. Efficacy weighted highest. Only human clinical data.
Scores evolve as new evidence is published. AI-assisted synthesis cross-referenced against Cochrane, PubMed, NIH, and WHO. Content reviewed and updated regularly.
Four stages toward hyper-personalized supplement recommendations.
The right supplement can genuinely change someone's quality of life. Better sleep. Less joint pain. More energy. Reduced anxiety. For people managing health conditions, nutrient deficiencies, or simply trying to age well, the difference between the right supplement and the wrong one can be profound. But finding honest information is nearly impossible — the supplement industry generates over $50 billion a year, and most of what you read online is written by someone trying to sell you something.
We built SupplementScore to fix that. Our goal is to use the latest advances in AI and machine learning to curate precise, personalized supplement regimens based on each individual's blood work, lab results, and eventually DNA.
We don't sell supplements. We don't accept sponsorships. We don't run affiliate links. Our goal is to keep SupplementScore free and transparent for everyone to use.
SupplementScore is an educational reference, not a medical device — not reviewed by the FDA, Health Canada, or any regulatory body. Scores reflect group-level clinical data; individual responses vary by genetics, diet, health status, medications, and pre-existing conditions. AI assists our content review and may miss nuances a clinician would catch — independently verify anything you act on. Supplement quality varies dramatically between brands; we do not test, certify, or endorse specific products. Nothing here is intended to diagnose, treat, cure, or prevent any disease, and nothing here substitutes for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing supplements — especially if you are pregnant, nursing, or on medications. In a medical emergency, contact your local emergency services immediately.
Evidence-based reviews, safety alerts, and deep dives into supplement science. Every article is checked against the peer-reviewed literature — no sponsors, no affiliate links, no hype.
Kava (Piper methysticum) is a plant from the Pacific Islands. For thousands of years, Pacific communities have ground its roots and steeped them in cold water to make a calming ceremonial drink. The active compounds, called kavalactones, reduce anxiety and produce a mild euphoria. Traditional root-only preparations have a long record of apparently safe use.
Over the last decade, kava has moved into Western supplement culture as an anxiety remedy and an alcohol alternative. Kava bars have opened across the United States, and capsules and concentrated extracts are sold in wellness shops and online. The problem: the Western supplement market has industrialized and concentrated a substance whose safety depends heavily on how it is prepared. In April 2026, the CDC published a detailed look at what has happened since — and the numbers are striking.
On April 3, 2026, the CDC's Morbidity and Mortality Weekly Report (MMWR) published an analysis of kava-related calls to America's Poison Centers from January 2000 through June 2025 (Towers et al., MMWR 75(12);2026). The authors reviewed 1,955 kava exposure calls across 25+ years. The headline finding: the share of calls rated as a "serious medical outcome" rose from about 12% in 2000 to a peak of 39% in 2024, then 32% in the first half of 2025. A "serious medical outcome" means the person needed medical treatment or had notable clinical effects — not that they died.
Call volume itself has climbed sharply in recent years, likely because kava bars and concentrated extracts have grown popular. A second pattern in the data: many of the worst calls involved co-use with kratom. In the first half of 2025, roughly 30% of kava calls also involved kratom, up from near zero in earlier years. Kratom has its own hepatotoxicity signal, and the combination appears to drive a disproportionate share of serious outcomes.
Importantly, the MMWR dataset did not identify any cases of acute liver failure from kava alone. Elevated liver enzymes — an early warning sign of liver stress — appeared in about 1.7% of kava-only calls and about 6.3% of kava-plus-kratom calls. That is higher than expected for a "natural" product, but it is different from the transplant-level liver failure cases that made headlines in Europe 20 years ago. Those European cases are real and are discussed below, but they came from a different pattern of use (concentrated extracts, often with other drugs or alcohol) and they are not what the 2026 CDC data describe.
The CDC authors recommended that healthcare providers ask patients directly about kava and kratom use when evaluating unexplained liver enzyme elevations, because patients often do not volunteer supplement use.
Western consumers are often unaware of a key distinction. Traditional kava uses only the root, prepared as a cold-water extraction. The kavalactone dose is modest and fairly consistent, and the process leaves behind certain plant compounds found in the stem, leaves, and peelings that are linked to liver toxicity.
Most Western commercial kava products — capsules, concentrated extracts, and powders marketed as "full-spectrum" — are made differently. Early investigations into kava-associated liver injury in Germany and Switzerland in the early 2000s (which led to temporary bans in several European countries) found that many implicated products mixed "noble" and "tudei" kava varieties, used above-ground plant parts, and concentrated kavalactones well above the levels delivered by traditional drinks.
Flavokavain B, a chalcone compound present in kava leaves and stem bark but at very low levels in root preparations, has been identified in lab and animal studies as a likely contributor to liver toxicity. It can trigger programmed cell death in liver cells at concentrations reachable with concentrated extracts. Traditional root-only preparations contain very little flavokavain B; whole-plant or above-ground-part extracts contain substantially more.
The result: people buying kava supplements online cannot usually tell whether a product uses root-only noble kava at traditional strength, or a concentrated whole-plant extract that may carry a very different risk. Most labels do not disclose this clearly.
Certain groups face sharply higher risk from kava and should avoid it:
Genetic variation in CYP2D6, a liver enzyme involved in kavalactone metabolism, may help explain why some people develop liver injury at doses others tolerate. That individual variability makes population-level risk hard to predict.
Germany, France, Switzerland, and Canada issued bans or strong warnings on kava products in the early 2000s following reports of liver failure. Germany lifted its ban in 2014 after its Federal Institute for Risk Assessment (BfR) concluded that the risk was tied mainly to non-traditional extracts, and that water-based root extracts had a different risk profile. The UK Medicines and Healthcare products Regulatory Agency (MHRA) still maintains restrictive guidance.
The U.S. FDA issued a consumer advisory in 2002 noting rare but severe liver injury. The agency has not banned kava but continues to monitor adverse events through its MedWatch system. The 2026 CDC MMWR escalates official concern given the growth of kava bars, concentrated extracts, and kratom co-use.
If you use kava supplements or go to kava bars, the most important steps are: avoid daily use, avoid combining with alcohol, kratom, or sedative medications without medical guidance, and watch for early signs of liver stress — unusual fatigue, nausea, yellowing of skin or eyes (jaundice), dark urine, or pain in the right upper abdomen. If any of those show up, stop use and see a doctor. If you use kava regularly, ask your doctor about checking liver enzymes (AST, ALT, bilirubin).
Kava's anxiety-reducing effect is real and the plant carries a cultural legitimacy that deserves respect. But the Western supplement market has concentrated and industrialized a substance whose safety depends on preparation method, dose, and what else you are taking — and it has done so without enough warning to the consumer.
Psyllium husk is derived from the seeds of Plantago ovata — a humble desert plant native to India, Pakistan, and the eastern Mediterranean — and is the active ingredient in Metamucil. It is quietly one of the most thoroughly studied dietary supplements in existence. More than 100 randomized controlled trials have tested its effects on cholesterol, blood sugar, blood pressure, bowel function, satiety, and body composition. It has an FDA-authorized health claim, recommendations from the American Heart Association, the American Diabetes Association, and the American College of Gastroenterology, and a safety profile that is almost unrivaled for a supplement with measurable clinical effects.
And yet — scroll TikTok, open any wellness newsletter, walk into a GNC — and it is the creatine tubs, ashwagandha capsules, and NMN bottles that get the attention. Psyllium gets a dusty shelf next to the stool softeners. This article argues that the quiet, boring fiber on the bottom shelf is one of the highest-leverage supplements most people aren't taking.
Psyllium is off-patent, cheap, and commoditized. A bag lasts months and costs less than a single serving of a trendy greens powder. There is no margin to fund influencer campaigns, no proprietary blend to trademark, and no Netflix documentary coming. Its obscurity in wellness culture says more about marketing incentives than about the science.
Psyllium has been used medicinally for at least 2,500 years. It appears in Ayurvedic texts (where it is called isabgol), in classical Persian medicine, and in European pharmacopoeias by the 16th century. In the United States, it entered mainstream awareness in 1934 when Procter & Gamble launched Metamucil, marketing it as a gentle laxative. For decades it was treated as a simple bulking agent and nothing more.
The shift began in the 1980s, when controlled trials started showing that psyllium did something no other laxative did: it consistently lowered LDL cholesterol. By 1998, the FDA had reviewed enough evidence to authorize a formal health claim — only the second soluble fiber (after oat beta-glucan) to achieve this. Today more than a thousand PubMed-indexed studies reference psyllium.
The magic of psyllium is physical, not chemical. When mixed with water, its mucilaginous outer layer absorbs 10–40× its weight in liquid and forms a thick, viscous gel. That gel does four clinically measurable things as it moves through the gut:
Crucially, psyllium is only partially fermented. Unlike inulin or pure beta-glucan, most of the gel remains intact all the way through the small intestine, giving it time to bind bile acids and blunt glucose absorption before the colonic bacteria get to it. This is why it is unusually effective across multiple organ systems from a single dose.
The FDA authorized a soluble-fiber heart-health claim for psyllium in 1998 after reviewing 67 human trials. A 2018 meta-analysis in the American Journal of Clinical Nutrition (Jovanovski et al.) pooled 28 randomized controlled trials covering 1,924 participants and found psyllium lowered LDL by an average of 13 mg/dL and non-HDL cholesterol by 16 mg/dL. Effects are dose-responsive and show up within 3–4 weeks.
For perspective, a low-dose statin (rosuvastatin 5 mg, atorvastatin 10 mg) typically lowers LDL by 30–40 mg/dL, so psyllium is not a drug replacement. But 15 mg/dL is roughly half of what a low-dose statin does — delivered without muscle pain, liver monitoring, or a prescription. For primary prevention in people who don't need a statin yet, or as an add-on to diet and a statin, this is a meaningful effect. It is more than you will get from red yeast rice capsules, berberine, garlic, or any other OTC "natural cholesterol" product with anything close to the same evidence base.
Because psyllium gel slows gastric emptying and physically impedes glucose absorption in the small intestine, it flattens the post-meal glucose spike. A 2015 meta-analysis by Gibb et al. in the American Journal of Clinical Nutrition pooled 35 trials and found that in people with type 2 diabetes, psyllium lowered fasting glucose by ~37 mg/dL (~2.0 mmol/L) and HbA1c by ~0.4 percentage points. Effects scaled with baseline glycemic impairment: psyllium did almost nothing in euglycemic (non-diabetic) subjects, a modest amount in pre-diabetic subjects, and the most in poorly controlled diabetics.
This is why the American Diabetes Association's Standards of Care specifically endorses viscous fiber supplementation as a nutrition strategy. For someone with pre-diabetes or newly diagnosed T2D, 10–15 g of psyllium daily (split before meals) is one of the cheapest, most evidence-backed interventions available outside of diet and exercise.
Meta-analyses consistently show a small but statistically significant blood pressure effect from psyllium — about −2.0 mmHg systolic and −1.5 mmHg diastolic at 10–15 g/day, larger in hypertensive subjects. This is smaller than DASH-style dietary changes and smaller than any anti-hypertensive drug, but it is a free bonus on top of the lipid and glucose benefits.
Psyllium is one of the very few agents that works for both constipation and diarrhea — because its effect is mechanical, not stimulant. In constipation, the gel holds water and increases stool bulk, triggering the stretch reflex that drives peristalsis. In diarrhea-predominant IBS, the same gel absorbs excess water and slows transit, firming the stool.
A 2014 Cochrane-style review of laxatives for chronic constipation rated psyllium among the highest for efficacy and by far the best for long-term safety — unlike stimulant laxatives (senna, bisacodyl), it does not cause tolerance, rebound constipation, or electrolyte disturbances. The American College of Gastroenterology gives psyllium a strong recommendation for chronic idiopathic constipation and a conditional recommendation for IBS.
Psyllium's viscous gel slows gastric emptying, extending fullness after meals. Trials show modest but real weight loss (−2 to −4 kg over 8–12 weeks) when taken before meals in overweight subjects, independent of any deliberate calorie restriction. It is not a weight-loss drug — but as a preload before meals it reduces calorie intake by a small, repeatable amount, which compounds over time.
Perhaps the most damning comparison for wellness culture is not the effect sizes but the evidence base itself. Here is how psyllium stacks up against supplements that get 100× more attention:
Not all fibers do the same things. The key property for cholesterol and glucose effects is viscosity — how thick a gel the fiber forms. Here is how common fiber supplements compare:
A few simple rules separate "it worked" from "it did nothing" or "it made me bloated":
The safety profile is remarkable — psyllium has been consumed in gram doses daily by millions of people for decades. The most common adverse effects are gas, bloating, and a feeling of abdominal fullness in the first week, almost always self-limiting if you titrate up slowly. True allergic reactions are rare but documented (bakery and healthcare workers with chronic inhalation exposure are at highest risk).
Do not take psyllium if you have: known swallowing difficulty, a history of esophageal stricture, suspected or diagnosed bowel obstruction, severe gastroparesis, or are recovering from recent GI surgery. Patients on lithium or narrow-therapeutic-index drugs should consult their physician about timing.
You want plain, pharmaceutical-grade Plantago ovata husk — either as loose powder or as capsules. Things to look for on the label:
Psyllium has a larger, higher-quality evidence base than almost any supplement marketed for metabolic health. At 10–15 g/day it meaningfully lowers LDL cholesterol, blunts post-meal glucose, nudges blood pressure down, normalizes bowel function, and costs pennies per serving. If we rebuilt the supplement aisle around evidence rather than marketing, psyllium would be the first thing most people were told to try.
Benign prostatic hyperplasia is one of the most heavily marketed supplement categories. Most over-the-counter "prostate formulas" combine several botanicals with weak independent evidence. The honest read of the trial literature: alpha-1 bl…
Recurrent herpes labialis affects roughly 20–40% of adults at least once a year. Oral antivirals (acyclovir, valacyclovir) remain the strongest acute and suppressive interventions. Among supplements, three have credible RCT evidence for red…
Crohn's disease management is driven by 5-ASAs, immunomodulators, biologic agents, and (in some patients) surgery. Supplements address the high-prevalence nutritional deficiencies that accompany the disease, plus a few adjunctive anti-infla…
Dry eye disease is multifactorial — meibomian gland dysfunction, aqueous-deficient tear film, and inflammatory components all coexist in varying proportions. Topical management (artificial tears, anti-inflammatory drops, punctal plugs) rema…
Primary dysmenorrhea — the cramping pain at the start of menstruation without underlying pathology — affects roughly half of menstruating people. NSAIDs (ibuprofen, naproxen) and hormonal contraception remain the strongest interventions. Am…
IBS-C combines the abdominal pain of IBS with a constipation-dominant bowel habit. Differs from chronic functional constipation in that pain and bloating dominate the symptom picture. Supplements that work for IBS-C may worsen IBS-D and vic…
IBS-D is the diarrhea-dominant IBS subtype. Pharmacological options include rifaximin, loperamide, eluxadoline, and tricyclic antidepressants. Among supplements, peppermint oil and specific probiotic strains have the strongest RCT base — an…
Age-related macular degeneration is the leading cause of blindness in adults over 65 in developed countries. The AREDS and AREDS2 trials remain among the cleanest and most influential supplement trials in medicine, producing a specific form…
Non-alcoholic fatty liver disease (NAFLD, increasingly renamed MASLD) and its inflammatory variant NASH/MASH are the most common chronic liver diseases globally. Weight loss (≥10%) is the single largest intervention. Among supplements, vita…
Peptic ulcer disease is treated with H. pylori eradication (where positive) and PPI therapy. NSAID-induced ulcers require NSAID withdrawal where possible. Several supplements have credible RCT evidence for accelerated healing or symptomatic…
SupplementScore is a community effort. Clinicians, researchers, and developers make our data better every day — corrections, new evidence, or partnership all welcome.
Found something wrong? Tell us what's off and link a source — we triage every submission with a citation.